-
1
-
-
0000552969
-
Clinical pharmacology of imipramine and related antidepressant compounds
-
Klerman, G. L., J. O. Cole: Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol. Rev. 17 (1965)101-141
-
(1965)
Pharmacol. Rev.
, vol.17
, pp. 101-141
-
-
Klerman, G.L.1
Cole, J.O.2
-
2
-
-
0024359956
-
Hypersensitivity myocarditis and hepatitis associated with imipramine and its metabolite, desipramine
-
Morrow, P. I., N. J. Hardin, J. Bonadies: Hypersensitivity myocarditis and hepatitis associated with imipramine and its metabolite, desipramine. J. Forensic Sci. 34 (1989) 1016-1020
-
(1989)
J. Forensic Sci.
, vol.34
, pp. 1016-1020
-
-
Morrow, P.I.1
Hardin, N.J.2
Bonadies, J.3
-
3
-
-
0025038959
-
Effect of imipramine on liver function tests
-
Ramesh, C., R. Pohl, R. Balon, V. K. Veragani: Effect of imipramine on liver function tests (Letter). Pharmacopsychiatry 23 (1990) 56-57
-
(1990)
Pharmacopsychiatry
, vol.23
, pp. 56-57
-
-
Ramesh, C.1
Pohl, R.2
Balon, R.3
Veragani, V.K.4
-
4
-
-
0014422399
-
Cholestatic jaundice during imipramine therapy
-
Short, M. H., J. M. Burns, M. E. Harris: Cholestatic jaundice during imipramine therapy. J. Amer. Med. Ass. 206 (1968) 1791-1792
-
(1968)
J. Amer. Med. Ass.
, vol.206
, pp. 1791-1792
-
-
Short, M.H.1
Burns, J.M.2
Harris, M.E.3
-
5
-
-
0014414158
-
Lethal hepatic necrosis after therapy with imipramine and desipramine
-
Powell, W. J., J. Koch-Weser, R. A. Williams: Lethal hepatic necrosis after therapy with imipramine and desipramine. J. Amer. Med. Ass. 206 (1968) 642-645
-
(1968)
J. Amer. Med. Ass.
, vol.206
, pp. 642-645
-
-
Powell, W.J.1
Koch-Weser, J.2
Williams, R.A.3
-
7
-
-
0020076838
-
Toxic hepatitis and single daily dosage imipramine therapy
-
Moskovitz, R., C. L. DeVane, R. Harris, R. B. Stewart: Toxic hepatitis and single daily dosage imipramine therapy. J. Clin. Psychiatry 43 (1982) 165-166
-
(1982)
J. Clin. Psychiatry
, vol.43
, pp. 165-166
-
-
Moskovitz, R.1
DeVane, C.L.2
Harris, R.3
Stewart, R.B.4
-
8
-
-
0024309788
-
Transient hepatitis due to low dose neuroleptic medication
-
Bui, H. D., R. H. Chaney: Transient hepatitis due to low dose neuroleptic medication (Letter). Amer. J. Gastroenterol. 84 (1989) 578-579
-
(1989)
Amer. J. Gastroenterol.
, vol.84
, pp. 578-579
-
-
Bui, H.D.1
Chaney, R.H.2
-
9
-
-
0025308263
-
Hepatic failure associated with imipramine therapy
-
Shaefer, M. S., A. L. Edmunds, R. S. Markin, R. P. Wood, T. J. Pillen, B. W. Shaw Jr.: Hepatic failure associated with imipramine therapy. Pharmacotherapy 10 (1990) 66-69
-
(1990)
Pharmacotherapy
, vol.10
, pp. 66-69
-
-
Shaefer, M.S.1
Edmunds, A.L.2
Markin, R.S.3
Wood, R.P.4
Pillen, T.J.5
Shaw Jr., B.W.6
-
11
-
-
0018888047
-
Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy
-
Horst, D. A., N. D. Grace, P. M. LeCompte: Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy. Gastroenterology 79 (1980) 550-554
-
(1980)
Gastroenterology
, vol.79
, pp. 550-554
-
-
Horst, D.A.1
Grace, N.D.2
LeCompte, P.M.3
-
12
-
-
0017730783
-
Tricyclic antidepressants: A review of their toxicology
-
Fiori, M. G.: Tricyclic antidepressants: a review of their toxicology. Curr. Dev. Psychopharmacol. 4 (1977) 71-110
-
(1977)
Curr. Dev. Psychopharmacol.
, vol.4
, pp. 71-110
-
-
Fiori, M.G.1
|